Injectable epoetin formulations for erythropoietin replacement in anemia due to renal failure or malignancy. Acquired by procurement professionals from pharmaceutical wholesalers for deployment in dialysis centers, cancer treatment units, and hospitals via subcutaneous or intravenous routes.